Advertisement
Advertisement
U.S. markets open in 1 hour 47 minutes
S&P Futures
4,005.25 -14.50 (-0.36%) Dow Futures
32,066.00 -54.00 (-0.17%) Nasdaq Futures
12,320.75 -62.00 (-0.50%) Russell 2000 Futures
1,781.90 -7.60 (-0.42%) Crude Oil
109.08 -1.41 (-1.28%) Gold
1,799.30 -8.90 (-0.49%)
Dr. Reddy's Laboratories Limited (RDY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 50.25 |
| Open | 50.60 |
| Bid | 38.50 x 800 |
| Ask | 101.78 x 900 |
| Day's Range | 50.20 - 51.04 |
| 52 Week Range | 47.88 - 75.50 |
| Volume | |
| Avg. Volume | 216,583 |
| Market Cap | 8.441B |
| Beta (5Y Monthly) | 0.15 |
| PE Ratio (TTM) | 24.88 |
| EPS (TTM) | 2.04 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.34 (0.66%) |
| Ex-Dividend Date | Jul 08, 2021 |
| 1y Target Est | 67.70 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
23% Est. Return
Subscribe to Yahoo Finance Plus to view Fair Value for RDY
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Dr. Reddy's Laboratories LtdAnalyst Report: Dr. Reddy's Laboratories LimitedHeadquartered in India, Dr. Reddy’s Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the company’s sales are well dispersed across North America, India, and other emerging markets.RatingFair ValueEconomic Moat3 months agoMorningstar
- Business Wire
Dr. Reddy's Laboratories Announces the Launch of Posaconazole Delayed-Release Tablets in the U.S. Market
HYDERABAD, India & PRINCETON, N.J., April 20, 2022--Dr. Reddy's Laboratories announces the launch of Posaconazole Delayed-Release Tablets in the U.S. Market.
- Business Wire
Dr. Reddy's Laboratories Announces the Launch of Methylprednisolone Sodium Succinate for Injection, USP in the U.S. Market
HYDERABAD, India & PRINCETON, N.J., April 05, 2022--Dr. Reddy's Laboratories announces the launch of Methylprednisolone Sodium Succinate for Injection, USP in the U.S. Market.
- Business Wire
Dr. Reddy's Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany
AUGSBURG, Germany & VANCOUVER, British Columbia & HYDERABAD, India, April 01, 2022--Dr. Reddy's Laboratories and MediCane Health announce the launch of medical cannabis products in Germany.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
